Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Deep Heat Maximum Strength cream
1003020N0BIAHBA
|
Mentholatum (Topical) | Methyl salicylate | Musculoskeletal and Joint Diseases | 2,357 |
|
Diclofenac sodium 75mg gast res / Misoprostol 200microg tab
1001010C0AAAXAX
|
Diclofenac sodium (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 2,328 |
|
Diclofenac potassium 50mg tablets
1001010AGAAABAB
|
Diclofenac potassium | Diclofenac potassium | Musculoskeletal and Joint Diseases | 2,274 |
|
Naproxen 375mg gastro-resistant tablets
1001010P0AAAJAJ
|
Naproxen | Naproxen | Musculoskeletal and Joint Diseases | 1,996 |
|
Diclofenac sodium 50mg gast res / Misoprostol 200microg tab
1001010C0AAAMAM
|
Diclofenac sodium (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 1,922 |
|
Arthrotec 75 gastro-resistant tablets
1001010C0BLABAX
|
Arthrotec | Diclofenac sodium | Musculoskeletal and Joint Diseases | 1,903 |
|
Ibuprofen 200mg capsules
1001010J0AAAAAA
|
Ibuprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 1,868 |
|
Deep Relief gel
1003020P0BEAAAH
|
Deep Relief | Ibuprofen | Musculoskeletal and Joint Diseases | 1,842 |
|
Powergel 2.5% gel
100302010BCAAAA
|
Powergel | Ketoprofen | Musculoskeletal and Joint Diseases | 1,774 |
|
Feldene 0.5% gel
1003020R0BBAAAA
|
Feldene (Rubefacient) | Piroxicam | Musculoskeletal and Joint Diseases | 1,768 |
|
Diclofenac sodium 100mg modified-release capsules
1001010C0AAANAN
|
Diclofenac sodium (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 1,715 |
|
Ketoprofen 200mg modified-release capsules
1001010L0AAAJAJ
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | 1,612 |
|
Mestinon 60mg tablets
1002010Q0BBAAAB
|
Mestinon | Pyridostigmine bromide | Musculoskeletal and Joint Diseases | 1,605 |
|
Diclofenac sodium 100mg modified-release tablets
1001010C0AAAFAF
|
Diclofenac sodium (Systemic) | Diclofenac sodium | Musculoskeletal and Joint Diseases | 1,600 |
|
Methyl salicylate 30% / Menthol 8% cream
1003020N0AABABA
|
Methyl salicylate | Methyl salicylate | Musculoskeletal and Joint Diseases | 1,546 |
|
Arcoxia 90mg tablets
1001010AJBBABAB
|
Arcoxia | Etoricoxib | Musculoskeletal and Joint Diseases | 1,527 |
|
Penicillamine 250mg tablets
1001030F0AAAFAF
|
Penicillamine | Penicillamine | Musculoskeletal and Joint Diseases | 1,520 |
|
Lodine SR 600mg tablets
1001010E0BBADAD
|
Lodine | Etodolac | Musculoskeletal and Joint Diseases | 1,503 |
|
Baclofen 10mg/5ml oral solution sugar free
1002020C0AABGBG
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | 1,472 |
|
Arthrotec 50 gastro-resistant tablets
1001010C0BLAAAM
|
Arthrotec | Diclofenac sodium | Musculoskeletal and Joint Diseases | 1,436 |
|
Balmosa cream
1003020N0BDAAAK
|
Balmosa | Methyl salicylate | Musculoskeletal and Joint Diseases | 1,408 |
|
Dantrolene 100mg capsules
1002020J0AAABAB
|
Dantrolene sodium (Systemic) | Dantrolene sodium | Musculoskeletal and Joint Diseases | 1,407 |
|
Aceclofenac 100mg tablets
100101080AAAAAA
|
Aceclofenac | Aceclofenac | Musculoskeletal and Joint Diseases | 1,380 |
|
Methotrexate 10mg/0.2ml inj pre-filled disposable devices
1001030U0AACECE
|
Methotrexate (Rheumatism) | Methotrexate | Musculoskeletal and Joint Diseases | 1,370 |
|
Arcoxia 60mg tablets
1001010AJBBAAAA
|
Arcoxia | Etoricoxib | Musculoskeletal and Joint Diseases | 1,351 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.